Medicare覆盖的心力衰竭患者再入院趋势
本研究回顾性分析2008年1月至2015年6月期间12,973,853例以心力衰竭为主要或次要诊断的Medicare住院病例,比较主要心衰住院与其他住院后30天风险调整再入院率趋势。结果显示,所有队列再入院率在《平价医疗法案》通过后开始下降,至2012年10月医院再入院减少计划实施后趋于稳定,但再入院率仍较高。
要点
- 心衰患者常因其他原因住院,且这些住院后再入院率较高。
- 政策变化后,主要和次要心衰住院的再入院率均下降。
- 两组再入院率仍处高位,需针对所有心衰住院患者的干预措施。
核心结论
- 心衰患者常因其他原因住院,且再入院率高;政策变化使主要和次要心衰住院的再入院率均下降,但仍需持续干预。
研究设计与样本
- 回顾性研究,纳入2008年1月至2015年6月期间12,973,853例Medicare住院病例(主要或次要诊断心衰)。
- 住院分为主要心衰住院、主要急性心肌梗死或肺炎伴次要心衰住院、其他住院伴次要心衰三组。
- 采用线性样条回归模型分析各队列风险调整30天全因再入院率趋势及队列间差异趋势。
主要发现
- 2010年3月《平价医疗法案》通过前,三组风险调整30天再入院率稳定,月均率分别为26.1%、24.9%、24.4%。
- 《平价医疗法案》通过后,三组再入院率分别以每年1.09%(95%CI:0.51%至1.68%)、1.24%(95%CI:0.92%至1.57%)、1.05%(95%CI:0.52%至1.58%)下降,直至2012年10月医院再入院减少计划实施后趋于稳定。
临床怎么用
- 临床应关注所有心衰住院患者(无论主要或次要诊断),因其再入院风险均较高。
- 针对心衰患者的再入院预防策略应覆盖因其他原因住院的心衰患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Medicare Hospital Readmissions Reduction Program has led to fewer readmissions following hospitalizations with a principal diagnosis of heart failure (HF). Patients with HF are frequently hospitalized for other causes. OBJECTIVES: This study sought to compare trends in Medicare risk-adjusted, 30-day readmissions following principal HF hospitalizations and other hospitalizations with HF. METHODS: This was a retrospective study of 12,973,853 Medicare hospitalizations with a principal or secondary diagnosis of HF between January 2008 and June 2015. Hospitalizations were categorized as follows: principal HF hospitalizations; principal acute myocardial infarction or pneumonia hospitalizations with secondary HF; and other hospitalizations with secondary HF. The study examined trends in risk-adjusted, 30-day, all-cause readmission rates for each cohort and trends in differences in readmission rates among cohorts by using linear spline regression models. RESULTS: Before passage of the Affordable Care Act in March 2010, risk-adjusted, 30-day readmission rates were stable for all 3 cohorts, with mean monthly rates of 26.1%, 24.9%, and 24.4%, respectively. Risk-adjusted readmission rates started declining after passage of the Affordable Care Act by 1.09% (95% confidence interval [CI]: 0.51% to 1.68%), 1.24% (95% CI: 0.92% to 1.57%), and 1.05% (95% CI: 0.52% to 1.58%) per year, respectively, until implementation of the Hospital Readmissions Reduction Program in October 2012 and then stabilized for all 3 cohorts. CONCLUSIONS: Patients with HF are often hospitalized for other causes, and these hospitalizations have high readmission rates. Policy changes led to decreases in readmission rates for both principal and secondary HF hospitalizations. Readmission rates in both groups remain high, suggesting that initiatives targeting all hospitalized patients with HF continue to be warranted.
引用
- Blecker S, Herrin J, Li L, et al. Trends in Hospital Readmission of Medicare-Covered Patients With Heart Failure. J Am Coll Cardiol. 2019. PMID: 30846093. doi:10.1016/j.jacc.2018.12.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。